Development of iPSC-Derived Gamma Delta T Cell Therapies for Treatment of Liquid & Solid Tumors

Time: 3:30 pm
day: Day Two


  • Harnessing the power of induced pluripotent stem cells (iPSCs) to develop novel allogeneic CAR-T cell therapies for cancer
  • Multiplex engineering of iPSCs to develop allogeneic Gamma Delta T cells that can safely and effectively mediate anti-tumor immunity
  • CAR design strategies that address disease-specific challenges